We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Acco Brands
ACCO
$362M
| $629K | ﹤0.01% |
209,666
+1,566
| +0.8% | +$5.9K |
|
2727
AtaiBeckley Inc
ATAI
$2.65B
| $627K | ﹤0.01% |
177,123
-2,852
| -2% | -$10.7K |
|
2728
Clearfield
CLFD
$414M
| $624K | ﹤0.01% |
23,566
+128
| +0.5% | +$3.9K |
|
|
LAC
2729
Lithium Americas
LAC
$1.02B
| $623K | ﹤0.01% |
157,284
| – | – |
|
2730
MoonLake Immunotherapeutics
MLTX
$1.62B
| $623K | ﹤0.01% |
33,417
-604,017
| -95% | -$10M |
|
2731
Target Hospitality
TH
$1.63B
| $620K | ﹤0.01% |
66,831
+409
| +0.6% | +$3.25K |
|
2732
Polestar Automotive Holding UK
PSNY
$2.18B
| $620K | ﹤0.01% |
+33,669
| New | +$609K |
|
2733
BlackRock MuniHoldings Fund
MHD
$600M
| $620K | ﹤0.01% |
54,947
+28,094
| +105% | +$330K |
|
2734
908 Devices
MASS
$292M
| $619K | ﹤0.01% |
101,074
+1,086
| +1% | +$6.8K |
|
|
SRTA
2735
Strata Critical Medical Inc
SRTA
$440M
| $614K | ﹤0.01% |
146,954
+962
| +0.7% | +$4.63K |
|
|
CNL
2736
Collective Mining Ltd
CNL
$1.17B
| $611K | ﹤0.01% |
34,896
| – | – |
|
2737
Standard BioTools
LAB
$343M
| $608K | ﹤0.01% |
661,204
+3,992
| +0.6% | +$4.83K |
|
|
DRUG
2738
Bright Minds Biosciences
DRUG
$700M
| $608K | ﹤0.01% |
8,329
+2,342
| +39% | +$189K |
|
2739
Paysafe
PSFE
$397M
| $606K | ﹤0.01% |
89,045
+16,379
| +23% | +$116K |
|
2740
Evolent Health
EVH
$522M
| $605K | ﹤0.01% |
265,142
-76,067
| -22% | -$241K |
|
2741
Codexis
CDXS
$181M
| $599K | ﹤0.01% |
367,443
+66,591
| +22% | +$94.9K |
|
2742
Jakks Pacific
JAKK
$272M
| $598K | ﹤0.01% |
30,005
+1,079
| +4% | +$20.9K |
|
2743
First Western Financial
MYFW
$313M
| $597K | ﹤0.01% |
24,272
+171
| +0.7% | +$4.34K |
|
2744
RGC Resources
RGCO
$230M
| $597K | ﹤0.01% |
27,055
+243
| +0.9% | +$5.25K |
|
2745
Clearwater Paper
CLW
$264M
| $596K | ﹤0.01% |
41,429
+216
| +0.5% | +$3.52K |
|
|
BETA
2746
Beta Technologies Inc
BETA
$4.24B
| $591K | ﹤0.01% |
+40,214
| New | +$825K |
|
2747
Clear Channel Outdoor Holdings
CCO
$1.23B
| $590K | ﹤0.01% |
248,928
-22,363
| -8% | -$50.6K |
|
2748
InMode
INMD
$867M
| $585K | ﹤0.01% |
42,752
| – | – |
|
|
ARDT
2749
Ardent Health
ARDT
$1.49B
| $585K | ﹤0.01% |
68,300
+37,614
| +123% | +$337K |
|
|
JKS
2750
JinkoSolar
JKS
$825M
| $584K | ﹤0.01% |
23,000
-5,100
| -18% | -$135K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.